Mariner’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-27,712
Closed -$221K – 3687
2025
Q1
$221K Buy
27,712
+647
+2% +$6.54K ﹤0.01% 2922
2024
Q4
$246K Buy
27,065
+3,982
+17% +$38.4K ﹤0.01% 2816
2024
Q3
$209K Buy
+23,083
New +$191K ﹤0.01% 2903
2024
Q2
– Sell
-11,072
Closed -$167K – 3285
2024
Q1
$167K Buy
+11,072
New +$201K ﹤0.01% 2816
2023
Q2
– Sell
-10,681
Closed -$275K – 2930
2023
Q1
$275K Sell
10,681
-9,196
-46% -$246K ﹤0.01% 2140
2022
Q4
$470K Buy
19,877
+525
+3% +$14.2K ﹤0.01% 1684
2022
Q3
$491K Sell
19,352
-3,542
-15% -$124K ﹤0.01% 1437
2022
Q2
$760K Buy
22,894
+5,760
+34% +$245K ﹤0.01% 1005
2022
Q1
$1.24M Buy
+17,134
New +$1.23M ﹤0.01% 868
2020
Q4
– Sell
-38,927
Closed -$8.53M – 806
2020
Q3
$8.53M Buy
+38,927
New +$8.24M 0.08% 209

Other funds holding TDOC

Mariner's TDOC Position: Q2 2025 in Review

Mariner sold out of Teladoc Health (TDOC) in Q2 2025, closing a stake of 27,712 shares — an estimated $221K sold.

Mariner first reported a position in TDOC in Q3 2020 and held it in 10 quarters. The position peaked at $8.53M in Q3 2020. 359 funds tracked by Wall St. Rank hold TDOC as of Q2 2025.

  • Mariner reported no remaining Teladoc Health position as of Q2 2025 after selling out during the quarter.
  • Mariner sold 27,712 Teladoc Health shares in Q2 2025, an estimated $221K.
  • Mariner first reported a position in Teladoc Health in Q3 2020 and held it in 10 quarters.
  • Mariner's Teladoc Health position peaked at $8.53M in Q3 2020.
  • 359 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2025.

Based on Mariner's 13F filing for Q2 2025, filed 14 Aug 2025.